Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075 for the Treatment of Obesity

CAMBRIDGE, Mass., March 8, 2024 /PRNewswire/ — Regor Therapeutics Group ("Regor"), a…

3D Printing Trailblazer ELEGOO Announces Initiative to Boost Women's Roles in STEM

SHENZHEN, China, March 8, 2024 /PRNewswire/ — In celebration of International Women’s…

Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range

Highlights Clarity recently reported that in its diagnostic Phase 1/2 trial, COBRA, 64Cu-SAR-bisPSMA…

Chairman of Avia Solutions Group Gediminas Ziemelis: 3 key trends in ACMI leasing as we enter 2024

DUBLIN, March 8, 2024 /PRNewswire/ — As we step into 2024, Gediminas…

SHEIN AND GOLD MEDALIST, SANYA RICHARDS-ROSS, JOIN FORCES TO CHAMPION WOMEN'S EMPOWERMENT FOR WOMEN'S HISTORY MONTH

The SHEIN x Sanya Richards-Ross Collection Features Stylish Pieces Spreading Messages of…

Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.

SEOUL, South Korea, March 8, 2024 /PRNewswire/ — Wellysis, a digital healthcare…

Mabwell to Present the Clinical Data of 9MW2821 in Cervical Cancer as Focused Plenary Oral Presentation at 2024 Society of Gynecologic Oncology Annual Meeting on Women's Cancer

SHANGHAI, March 8, 2024 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company…

iClick Interactive Asia Group Limited Announces Shareholders' Approval of Merger Agreement

HONG KONG, March 8, 2024 /PRNewswire/ — iClick Interactive Asia Group Limited…